-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The reporter learned from Guangzhou Exchange Group on the 29th that Guangzhou Drug and Medical Consumables Procurement Platform (hereinafter referred to as "Guangzhou GPO Platform") under Guangzhou Exchange Group recently set up a Hong Kong and Macao Drug Procurement Zone, and has completed the work
of hanging the network of two specifications of cardinib, which are urgently needed to import Hong Kong and Macao drugs for clinical purposes.
According to reports, the Guangzhou GPO Platform Hong Kong and Macao Drug Procurement Zone is the practice of implementing the "Guangzhou Nansha Overall Plan for Deepening Guangdong-Hong Kong-Macao Comprehensive Cooperation Facing the World" (referred to as the "Nansha Plan") and the "Guangdong-Hong Kong-Macao Greater Bay Area Drug and Medical Device Regulatory Innovation Development Work Plan" jointly issued by eight ministries and commissions including the State Medical Products Administration, and actively promoting the import of Hong Kong and Macao drugs urgently needed for clinical purposes and designated medical institutions to enter the platform, and dynamically adjust the key labels and dynamic adjustments of imported Hong Kong and Macao drugs urgently needed for clinical purposes, so as to facilitate medical institutions to purchase imported Hong Kong and Macao drugs
that have been urgently needed for clinical use through the special area.
It is reported that in accordance with the work requirements of "government organization, alliance procurement, and platform operation", after 4 years of rapid development, the transaction scope covers more than 2,000 medical institutions in 17 prefectures and cities in Guangdong Province, and the cumulative transaction scale has exceeded 100 billion yuan, realizing the standardization, institutionalization and normalization of pharmaceutical procurement, and forming a fair, transparent, convenient and efficient public procurement market environment
.
The Guangzhou GPO platform said that it will continue to pay attention to the adjustment of the catalog of the Guangdong Provincial Drug Administration and the Guangdong Provincial Health Commission, actively promote designated medical institutions to enter the platform, further improve the quality and efficiency of platform services, and do a good job in follow-up procurement transaction services
.
(End)
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
![benzyl N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}carbamate](https://file.echemi.com/fileManage/upload/goodpicture/20210823/m20210823171124543.jpg)
